Madrigal Pharmaceuticals, Inc. (MDGL)

501.35 -9.18 (-1.80%) USD  |  NASDAQ  |  Jan 13, 12:29
More

Madrigal Pharmaceuticals EPS Diluted from Continuing Operations (Quarterly)

EPS Diluted from Continuing Operations (Quarterly) Chart

View EPS Diluted from Continuing Operations (Quarterly) for MDGL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Continuing Operations (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years

View EPS Diluted from Continuing Operations (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Continuing Operations (Quarterly) Benchmarks

View EPS Diluted from Continuing Operations (Quarterly) Benchmarks
Start Trial
Eli Lilly & Co. Upgrade
Amgen, Inc. Upgrade
Pfizer Inc. Upgrade
Crinetics Pharmaceuticals, Inc. Upgrade
Amicus Therapeutics, Inc. Upgrade